KRISTOPHER SCHAMBER: Open Payments
NPI 1942590054 · SHERIDAN, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 16 payments from 7 companies in 2025. Trend: 2023 $268 · 2024 $283 · 2025 $330
Food & beverage: $290Education: $40
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 4 | $114 |
| Novo Nordisk Inc | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Lilly USA, LLC | 3 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Edwards Lifesciences Corporation | 1 | $20 |
| Amgen Inc. | 1 | $18 |
Products named: REZDIFFRA, BREZTRI, MOUNJARO, CAPLYTA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Wegovy, OTEZLA, Rybelsus.
Industry payments across WY — which companies pay providers there.
